PTC Therapeutics | PTCT - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Cytokinetics USD 6.83M 10.94M 2026-03
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Gilead Sciences USD 5.06B 314M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Xencor USD 42.23M 30.23M 2026-06